The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((3R,4S)-4-(6-(2-chloro-3,5-dimethoxyphenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)tetrahydrofuran-3-yl)acrylamide ID: ALA4790124
PubChem CID: 146488940
Max Phase: Preclinical
Molecular Formula: C23H24ClN5O5
Molecular Weight: 485.93
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3cc(OC)cc(OC)c3Cl)c(=O)n(C)c2n1
Standard InChI: InChI=1S/C23H24ClN5O5/c1-5-19(30)26-16-10-34-11-17(16)27-23-25-9-12-6-15(22(31)29(2)21(12)28-23)14-7-13(32-3)8-18(33-4)20(14)24/h5-9,16-17H,1,10-11H2,2-4H3,(H,26,30)(H,25,27,28)/t16-,17+/m0/s1
Standard InChI Key: WTKBTMUUWJPQPW-DLBZAZTESA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
41.2048 -10.2272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2037 -11.0509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9159 -11.4640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6296 -11.0504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6268 -10.2236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9141 -9.8184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4951 -11.4608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7878 -11.0453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7843 -12.6870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.5005 -12.2808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0729 -12.2757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0815 -11.4568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3772 -11.0397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6638 -11.4444 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.6592 -12.2664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3641 -12.6757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9116 -8.9971 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.6222 -8.5822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.3421 -11.4620 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.3434 -12.2834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9157 -12.2853 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
41.2075 -12.6907 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.7809 -13.5083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9452 -12.6712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.2355 -12.2588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1533 -11.4400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3507 -11.2617 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.9383 -11.9714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4819 -12.5856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3069 -13.3879 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5239 -13.6354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3489 -14.4378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5659 -14.6894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9161 -13.0847 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
7 10 1 0
8 12 1 0
11 9 1 0
9 10 1 0
2 7 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
6 17 1 0
17 18 1 0
4 19 1 0
19 20 1 0
3 21 1 0
10 22 2 0
9 23 1 0
15 24 1 0
25 24 1 1
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 25 1 0
29 30 1 1
30 31 1 0
31 32 1 0
32 33 2 0
31 34 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 485.93Molecular Weight (Monoisotopic): 485.1466AlogP: 2.15#Rotatable Bonds: 7Polar Surface Area: 116.60Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.52CX Basic pKa: 3.64CX LogP: 1.92CX LogD: 1.92Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.49Np Likeness Score: -0.24
References 1. Liu H,Niu D,Tham Sjin RT,Dubrovskiy A,Zhu Z,McDonald JJ,Fahnoe K,Wang Z,Munson M,Scholte A,Barrague M,Fitzgerald M,Liu J,Kothe M,Sun F,Murtie J,Ge J,Rocnik J,Harvey D,Ospina B,Perron K,Zheng G,Shehu E,D'Agostino LA. (2020) Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular Carcinoma., 11 (10): [PMID:33062171 ] [10.1021/acsmedchemlett.9b00601 ]